Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

From big pharma, to cancer research to a fast growing CRO, James Hitchin has gained multiple perspectives on a subject that has become his passion – medicinal chemistry.

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

The automotive sector – Toyota, in particular – is a rich source of inspiration for improving productivity.

The development of an optimized bioprocess requires a holistic approach tailored to the specific needs of the product.

The fourth industrial revolution – Industry 4.0 – represents a shift in manufacturing mentality. Is biopharma ready?

CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Global healthcare costs and demands are changing, and it’s time to look beyond mammalian cell lines.

Fighting counterfeit medicines is a noble goal, but the financial burden of safety features may affect access to medicines in unintended ways.